SCHEMBL9976677

SCHEMBL9976677

Cc1cc[nH]c(=S)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL259457 0.70
SCHEMBL24826394 0.67 LMNA (0.37)
SCHEMBL9372765 0.67
SCHEMBL13368081 0.66 CYP1A2 (0.44)
SCHEMBL22215588 0.66 CYP2A6 (0.44)
SCHEMBL22168190 0.62
SCHEMBL29556250 0.62 AHR (0.56)
SCHEMBL11994 0.62 AHR (0.56)
SCHEMBL30882 0.62 AHR (0.56)
SCHEMBL30138435 0.62 AHR (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118271290-A Continuous flow preparation method of trithio s-triazine compound 上海沃凯生物技术有限公司 2024-07-02 CN claimed
EP-3458440-B1 PYRIDINETHIONES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC USE FOR TREATING A PROLIFERATIVE, INFLAMMATORY, NEURODEGENERATIVE, OR IMMUNE-MEDIATED DISEASE NEUROTHERYX CANADA LTD (CA) 2022-07-27 EP claimed
CN-118271290-A Continuous flow preparation method of trithio s-triazine compound 上海沃凯生物技术有限公司 2024-07-02 CN disclosed
US-8835625-B2 Propargyl substituted nucleoside compounds and methods APPLIED BIOSYSTEMS, LLC (US) 2014-09-16 US disclosed
US-8835625-B2 Propargyl substituted nucleoside compounds and methods APPLIED BIOSYSTEMS, LLC (US) 2014-09-16 US disclosed
US-8344118-B2 Preparation and isolation of 5′ capped MRNA APPLIED BIOSYSTEMS, LLC (US) 2013-01-01 US disclosed
US-8344118-B2 Preparation and isolation of 5′ capped MRNA APPLIED BIOSYSTEMS, LLC (US) 2013-01-01 US disclosed
US-20120309953-A1 Propargyl Substituted Nucleoside Compounds and Methods Life Technologies Corporation (US) 2012-12-06 US disclosed
US-20120309953-A1 Propargyl Substituted Nucleoside Compounds and Methods Life Technologies Corporation (US) 2012-12-06 US disclosed
US-20120156751-A1 PREPARATION AND ISOLATION OF 5' CAPPED MRNA APPLIED BIOSYSTEMS, LLC (US) 2012-06-21 US disclosed
US-20120156751-A1 PREPARATION AND ISOLATION OF 5' CAPPED MRNA APPLIED BIOSYSTEMS, LLC (US) 2012-06-21 US disclosed
US-8093367-B2 Preparation and isolation of 5′ capped mRNA APPLIED BIOSYSTEMS, LLC (US) 2012-01-10 US disclosed
US-8093367-B2 Preparation and isolation of 5′ capped mRNA APPLIED BIOSYSTEMS, LLC (US) 2012-01-10 US disclosed
US-7998706-B2 Pyrimidine nucleobases APPLIED BIOSYSTEMS, LLC (US) 2011-08-16 US disclosed
US-7998706-B2 Pyrimidine nucleobases APPLIED BIOSYSTEMS, LLC (US) 2011-08-16 US disclosed
US-20100304389-A1 Preparation And Isolation of 5' Capped mRNA Life Technologies Corporation (US) 2010-12-02 US disclosed
US-20100304389-A1 Preparation And Isolation of 5' Capped mRNA Life Technologies Corporation (US) 2010-12-02 US disclosed
US-20100113759-A1 PROPARGYL SUBSTITUTED NUCLEOSIDE COMPOUNDS AND METHODS Life Technologies Corporation (US) 2010-05-06 US disclosed
US-20100113759-A1 PROPARGYL SUBSTITUTED NUCLEOSIDE COMPOUNDS AND METHODS Life Technologies Corporation (US) 2010-05-06 US disclosed
WO-2009058911-A2 PREPARATION AND ISOLATION OF 5' CAPPED MRNA APPLIED BIOSYSTEMS INC. (US) 2009-05-07 WO disclosed